F
Fabien Zoulim
Researcher at French Institute of Health and Medical Research
Publications - 716
Citations - 40988
Fabien Zoulim is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 96, co-authored 641 publications receiving 35807 citations. Previous affiliations of Fabien Zoulim include Hotel Dieu Hospital & University of Orléans.
Papers
More filters
Journal ArticleDOI
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
Pierre Pradat,Victor Virlogeux,Marianne Maynard,Mathilde Leclercq,Giorgiana Hatu,Majid Amiri,Fanny Lebossé,Patrick Miailhes,Fabien Zoulim,Marie-Claude Gagnieu,François Bailly +10 more
TL;DR: The results indicated a reversible increase in RBV bioavailability after telaprevir exposure, which might be linked to the impairment of the GFR, and suggest that RBV pharmacological monitoring may be clinically relevant, especially in the context of first-generation HCV protease inhibitor-based therapy.
Journal ArticleDOI
Off-therapy cure of hepatitis delta after 3 years of bulevirtide monotherapy in a patient with compensated advanced cirrhosis
M. Anolli,Elisabetta Degasperi,Sara Colonia Uceda Renteria,D. Sambarino,Marta Borghi,Riccardo Perbellini,Alessandro Loglio,Caroline Scholtes,Floriana Facchetti,Mirella Fraquelli,Andrea Costantino,Ferruccio Ceriotti,Fabien Zoulim,Pietro Lampertico +13 more
Journal ArticleDOI
Viral hepatitis Elimination: Towards a hepatitis free world.
Maria Buti,Antonio Craxì,Graham R. Foster,Mojca Matičič,Francesco Negro,Stefan Zeuzem,Fabien Zoulim +6 more
TL;DR: In this paper , a special conference was held to examine current efforts and metrics to assess progress towards elimination of chronic viral hepatitis in the United States, and the World Health Organization defined the targets for elimination, but it is unclear how these can be achieved and how they should be measured.
Journal ArticleDOI
Copper Isotope Evidence of Oxidative Stress–Induced Hepatic Breakdown and the Transition to Hepatocellular Carcinoma
Philippe Telouk,Marie-Laure Plissonnier,Philippe Merle,Fabien Zoulim,Nadim Fares,Paule Guilloreau,Romain Parent,Justine Bacchetta,Marc Danan,Sergio Carandina,Francis Albarède +10 more
TL;DR: In this article , copper isotope variations (δ65Cu) were evaluated in the serum of HCCnegative and HCC-positive patients as a biomarker of hepatic failure.
Journal ArticleDOI
Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.
Rajneesh Kumar,Rajneesh Kumar,Barbara Testoni,Judith Fresquet,Tony Kiat Hon Lim,Ying Hao,Hui Hui Tan,Wan Cheng Chow,Fabien Zoulim +8 more
TL;DR: Serum, intrahepatic viral‐markers, and long‐term follow‐up of prevalent genotypes (GT) B and C in patients with biopsy proven advanced fibrosis showed no difference in serum HBV‐DNA, qHBsAg or intra hepatic HBv‐DNA was seen in the two genotypes.